Crossmark

MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147

Published Online: 2019-06-13

Published Print: 2019-12

Authors

Wang, Cheng

Xu, Cheng

Niu, Ruijie

Hu, Guangfu

Gu, Zhangyuan

Zhuang, Zhigang http://orcid.org/0000-0002-7827-4402
Funding

Funding for this research was provided by:

Key Medical Specialty Fund Projects of Shanghai (ZK2015A07)

Projects of Shanghai Municipal Health and Family Planning Commission (201540259)

Projects of Shanghai Science and Technology Committee (15411964800)
License Information

Text and Data Mining valid from 2019-06-13

Version of Record valid from 2019-06-13
More Information

Article History

Received: 27 November 2018

Accepted: 5 June 2019

First Online: 13 June 2019

Ethics approval and consent to participate

: The study was approved by medical ethics committee of the Central Hospital of Huangpu District and conforming to the principles outlined in the Declaration of Helsinki for the use of human tissue or subjects and after obtaining written informed consent from the patient.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current